Legend Biotech Adr Rep (LEGN)
LEGN · Health Care · 
China
Legend Biotech Adr Rep (LEGN) is a Chinese company in the Health Care sector. The stock has its largest weight in IS3N (MSCI EM IMI), at 0.01%. Anyone who holds an ETF containing Legend Biotech Adr Rep also has an indirect stake in the company.
Data and Charts: Legend Biotech Adr Rep
Key Data for Legend Biotech Adr Rep
Legend Biotech Adr Rep Stock Price Chart
The Legend Biotech Adr Rep chart shows daily closing prices and is set to the current year by default. The stock is down 14.7% year to date and down 40.5% over twelve months. The last recorded close on November 12, 2026, was $18.54, at 10% of the 52-week range.
The chart shows the US listing in US dollars. On the home exchange the price can differ, since the currency and trading hours are different. For depositary receipts (ADRs), one receipt is not always one share.
Price series from our database since Sep 23, 2024, 538 daily values.
Legend Biotech Adr Rep Stock Performance
| Year to date | -14.7% | 1 year | -40.5% |
|---|---|---|---|
| 1 month | +3.7% | 3 months | -8.5% |
| Calendar year 2025 | -33.2% |
Measured in euros, Legend Biotech Adr Rep is down 9.6% year to date and down 37.9% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Legend Biotech Adr Rep
What ETF Is Legend Biotech Adr Rep In?
Legend Biotech Adr Rep has below-average ETF coverage and is held by 2 of the 104 ETFs we track, which together follow 2 indices. That puts the stock in more ETFs than 24.8% of the 4,339 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| IS3N | MSCI EM IMI | 0.01% | €0.10 |
| IUSQ | MSCI ACWI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Legend Biotech Adr Rep, based on each fund's latest holdings list.
Legend Biotech Adr Rep Weight in iShares Core MSCI EM IMI (IS3N) Since 2021
In iShares Core MSCI EM IMI (IS3N), Legend Biotech Adr Rep had a weight of 0.02% on Dec 31, 2021 and 0.01% on Nov 12, 2026. The fund tracks the MSCI EM IMI. Its share peaked at 0.05% on Jun 30, 2023. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Legend Biotech Adr Rep overlaps with the rest of a portfolio.
What Legend Biotech Adr Rep Executives and Directors Traded Recently
| Date | Person | Type | Shares | Price |
|---|---|---|---|---|
| Sep 29, 2026 | Sanders Corazon (Corsee) D. Director | Sell | 27,370 | – |
| Sep 21, 2026 | Santos Carlos E Officer, Chief Financial Officer | Sell | 5,430 | – |
The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded.
“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 389 of 506 tracked companies and purchases at 70.
Stocks With ETF Exposure Similar to Legend Biotech Adr Rep
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Legend Biotech Adr Rep | – | – | -40.5% | 63.4% | – | – |
| Baidu | 2 | – | – | – | – | – |
| Tencent Music Entertainment Group | 2 | – | -52.6% | 49.4% | – | – |
| Full Truck Alliance | 2 | – | -32.9% | 44.0% | – | – |
 Gazprom | 2 | – | – | – | – | – |
 PDD Holdings ADS | 2 | – | -43.0% | 41.3% | 22.7% | +14.5% |
| Kanzhun American Depository Shares | 2 | – | -41.5% | 50.7% | 33.1% | +17.3% |
| TAL Education Group Adr Reptg | 2 | – | -14.4% | 54.0% | 17.6% | +33.7% |
| Vipshop Holdings Sponsored ADS Rep | 2 | – | -34.1% | 37.1% | 6.8% | – |
These stocks reach a portfolio through largely the same funds as Legend Biotech Adr Rep. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Risk and Correlation: Legend Biotech Adr Rep
Legend Biotech Adr Rep Risk Metrics
The close on Nov 12, 2026, was 63.1% below the highest close since Sep 23, 2024. That high was reached on Oct 10, 2024. When the S&P 500 rose or fell 1%, Legend Biotech Adr Rep moved 0.62% on average in the same direction (past 252 trading days). The correlation of 0.11, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Legend Biotech Adr Rep.
What Legend Biotech Adr Rep Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Plug Power Inc. | +0.42 | |
| Upstart Holdings Inc. | +0.41 | |
| Novavax Inc. | +0.39 | |
| Agilent Technologies Inc. | +0.36 | |
| Sigma Lithium Corporation | +0.36 | |
| Ulta Beauty Inc. | +0.36 | |
| Everest Group Ltd. | -0.24 | |
| W. R. Berkley Corporation | -0.24 | |
| Aflac Incorporated | -0.23 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.